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Abstract 
Purpose: To describe caffeic acid-based pharmacokinetics of methanol extract of seed of Syzygium 
cumini L. in rats.  
Methods: A dose of the extract (500 mg, equivalent to 37.135 mg caffeic acid) was administered orally 
to 6 male Wister rats, weighing 200 ± 10 g. Blood samples (0.5 mL), collected from the tail vein at 0, 15, 
30, 60, 120, 240 and 720 min, were processed and analyzed using high performance liquid 
chromatography and detected with florescent light detector (FLD).  
Results:  Following the administration of the extract, caffeic acid achieved maximum plasma 
concentration (5.96 ± 0.49 µg/mL) in 1.0 h which was also the time to achieve maximum concentration 
(Tmax). Mean resident time (MRT) and half-life (t1/2) were 4.092 ± 0.94 h and 0.14 ± 0.01 h, respectively.  
Conclusion: The results indicate that absorption of caffeic acid from the oral route is fast, but lower 
amounts are absorbed. The method developed for the extraction of caffeic acid from the plasma and 
HPLC determination may be useful in establishing phyto-bioequivalence between Syzygium cumini 
seed products.  
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Syzygium cumini L. (Myrtaceae), locally known 
as Jamun, is well-known plant for its nutritional 
and medicinal properties. Almost every part of 
the plant is used medicinally [1-2], however, the 
seeds in sweetish-sour berries are the most 
important one being used to treat a variety of 
ailments especially diabetes mellitus [3]. Seed 
powder in combination with mango kernels is 
reported to be effective for treating diarrhea, 
dysentery, spleen enlargement and enurea [3,4]. 
Other parts of the plant have also been exploited 
by natural product researchers for their 
antioxidant, anti-inflammatory, gastroprotective, 
anti-fertility [3], antibacterial [5,6], antipyretic [7], 
anticonvulsant [8], and antineoplastic [9] 
potentials. To the best of our literature review, no 
report on pharmacokinetics studies of extracts of 
the seed was found. 
 
Pharmacokinetics evaluation of the drug has a 
pivotal role in selection of its route of 
administration, dose, dosing interval and 
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exposure, etc. In the recent past, this neglected 
aspect of natural products has grasped the 
attention of researchers, which is evident by a 
number of pharmacokinetics studies of plant-
based products/extracts [10-12]. Unlike 
pharmaceuticals, phytopharmaceuticals are a 
mixture of known and mostly unknown 
components, hence are difficult to be 
investigated for pharmacokinetics. Another 
limitation is lack of analytical methods and 
unavailability of analytical standards. Li et al 
categorized markers into eight categories, which 
may be used as analytical standards [13].  
 
The seeds contain caffeic acid which is a 
polyphenolic compound possessing antioxidant 
[14], immunomodulatory [15], antimicrobial [16], 
antiaging [17], anti-inflammatory [18] and 
antidiabetic [19] activities. Therefore, the aim of 
this study is to use caffeic acid (Figure 1) as an 
analytical marker to investigate its 








Chemicals and solvents 
 
Caffeic acid (Sigma Aldrich), HPLC grade 
methanol and acetonitrile (Merck, Germany), 
EDTA coated blood collection tubes and 
disposable syringes (BD) and 0.45 µm pore 
PTFE filters (Whatman, Maidstone, England) 
were procured from the local supplier. Ultra-





In May 2010, 28 kg ripe berries of the plant were 
purchased from the fruit market of Multan, 
Pakistan. The material was authenticated by Prof 
Dr Zaheer ud Din Khan (a taxonomist), 
Department of Botany, Government College 
University (GCU), Lahore, Pakistan. A voucher 
specimen (no. G. C. Bot. Herb 853) was 
deposited in the herbarium of GCU. The seeds 
were separated, washed with water and dried in 
an oven at 50 oC. The material was then crushed 
using colloidal mill, dried under shade for 4 
weeks and pulverized. Five hundred grams 
powdered material was extracted sequentially by 
Soxhlet apparatus using petroleum ether, 
chloroform and methanol.  The extracts were 
filtered and dried in vacuo at 40 oC.  
 
Development and validation of HPLC method  
 
Extraction of caffeic acid from plasma 
 
Rat plasma (500 µL) was spiked with 500 µL 
caffeic acid solution (100 µg/mL) and mixed by 
vortex for 1min. Then, 200 µL acetonitrile was 
added and mixed by vortex for 5 s. Finally, 800 
µL methanol was added and mixed by vortex for 
5 s. The contents were subjected to 
centrifugation at 2700 rpm for 10 min at 25 oC. 
The supernatant was collected, dried with liquid 
nitrogen and the residue was reconstituted with 
100 µL methanol. 
 
High Performance Liquid Chromatography 
(HPLC) 
 
HPLC system (1200 series, Agilent 
Technologies, Waldronn, Germany), equipped 
with degasser (G1379 A), quaternary pump 
(G1310 A), auto sampler (G1329 A), column 
oven (G1316 A) and florescent light detector (G 
1321 A) was used in the study. The system was 




A volume of the sample/standard (20 µL) was 
eluted through column - Eclipse X DB-C18 (5 
µm, 4.6 X 150 mm) - at flow rate of 1.0 mL/min, 
using isocratic mobile phase; water : acetonitrile : 
acetic acid (79 : 20 : 1.0, v/v/v). The column was 
maintained at 25 oC and the detection was 
carried out using florescent light detector (FLD); 







The rat plasma samples were spiked by caffeic 
acid solutions having concentration 2.5, 5.0, 
10.0, 25.0, 50.0 and 100.0 µg/mL and extracted 
as mentioned above. The resulting samples were 
analyzed in triplicate at the mentioned 
chromatography conditions. The response of the 
detector (peak height) was plotted against the 
respective concentration and linearity was 
evaluated visually by observing the correlation 
coefficient. 
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Recovery, accuracy and precision 
 
Three concentrations of caffeic acid solution (2.5, 
50.0 and 100.0 µg/mL) were used to determine 
recovery, accuracy and precision. After spiking 
the plasma and extraction, the three samples 
were analyzed in triplicate and amount of caffeic 
acid was determined from the calibration curve. 
The determined amount was compared to the 
true value (spiked amount) and presented as % 
mean recovery ± SD. 
 
For intraday accuracy and precision, each of the 
three standard solutions was analyzed in the 
same day for six times at chromatographic 
conditions mentioned above and the amount 
calculated from the calibration curve was 
compared to the true value to determine 
accuracy. Relative standard deviation was 
calculated as precision. 
 
For inter day accuracy and precision, each of the 
three standard solutions was analyzed once daily 
for six consecutive days. The amount of the drug 
was determined from the calibration curve on 
each day. The determined values were used to 




The samples were analyzed by changing mobile 
phase composition (±2 %), Column temperature 
(±1 %) and detector parameters; excitation (±3 




The study was conducted as per the research 
protocol approved by Animal Ethics Committee, 
University College of Pharmacy, University of the 
Punjab, Lahore, Pakistan (ref no. 




Six, male, Wistar rats, weighing 200 ± 10 g, 
taken from University of Veterinary and Animal 
Sciences, Lahore, Pakistan, were allowed to 
acclimatize for seven days at Animal House, 
University College of Pharmacy, University of the 
Punjab, Lahore, Pakistan. Standard pellet diet 
and tap water were provided ad libitum. The 
animals were handled using Guideline 22 for the 
Housing of Mice in Scientific Institutions20. 
 
Dose preparation and administration 
 
The dried methanol extract having 74.27 mg/g 
caffeic acid was suspended in 1:1 (v/v) mixture of 
water and polyethylene glycol (PEG-400) to get a 
solution having concentration 250 mg/mL. Then, 
2 mL suspension (500 mg extract, equivalent to 
37.135 mg caffeic acid) was administered orally 




From each rat, 0.5 mL blood was taken from the 
tail vein at 0 h (pre dose), 0.25, 0.50, 1.00, 2.00, 
4.00 and 12.00 h. The plasma was collected after 
centrifugation of blood at 2700rpm for 10 min at 
25 oC, which was then processed and analyzed 
as mentioned above. 
 
Determination of pharmacokinetic parameters 
 
Analytical data of each rat were used to plot a 
curve between plasma concentration of caffeic 
acid and time. Total area under the plasma 
concentration time curve (AUC0-∞) was calculated 
using the trapezoidal rule and as in Eqs 1 and 2. 
 
AUC0-∞= ∑ (AUC0-1+AUC1-last+AUClast-∞) …… (1) 
 
AUClast-∞ = Clast/Kel …………….……………… (2) 
 
A plot between a cross product of concentration 
and time (CT) was used to calculate the area 
under the first moment curve (AUMC). Mean 
resident time (MRT) was obtained by dividing 
AUMC0-∞ with AUC0-∞.  
 
The maximum plasma concentration (Cmax, 
ng/mL) and time to it (Tmax) were taken directly 
from plot. The elimination rate constant (Kel, h-1) 
was calculated by the linear regression on the 
terminal phase of the plasma concentration time 
plot and using Eq 3. 
 
Kel = ln C1 - ln C2/T2- T1 ……………………… (3) 
 
The half-life (t1/2) was calculated by dividing 
0.693 with Kel, while clearance (Cl) and volume 
of distribution (VD) were determined as in Eqs 4 
and 5. 
 
Cl = actual dose administered/AUC0-∞ ……. (4) 
 
VD = Clearance/elimination rate constant  
 




The samples were analyzed in triplicate and the 
results were presented as mean ± SD. The 
pharmacokinetics parameters were presented as 
mean of six rats ± SD. 
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Plasma-extracted caffeic acid  
 
The method of extraction of caffeic acid from 
plasma was found to be appropriate because no 
interference of endogenous compounds of the 
plasma was observed (Figure 2 and 3). In this 
method, the retention time of caffeic acid was 
found to be 3.1 min, which was lesser than some 
of the studies, wherein it was 10.9 min and 15 
min [21,22]. These results indicated that by using 
the present procedure, analysis could be 
completed in lesser time and consuming fewer 
solvents. 
 
Validity of the method 
 
The method was found to be linear in the whole 
range of samples investigated (2.5-100.0 µg/mL) 
with the linear regression equation (Y = 
0.258+0.1744) and R2 = 0.9991. This equation 
indicated that the plot was linear and the 
intercept was almost approaching to zero. Useful 
range was determined that could be used to 
quantify the drug in the samples. Moreover, peak 
symmetry and capacity factor indicated that the 
method was specific. 
 
The results of LOD and LOQ values of caffeic 
acid were found to be 0.70 µg/mL and 2.12 
µg/mL, respectively, which indicated that the 
method was sensitive. The results of the 
recovery, intraday and inter day accuracy and 
precision are given in Table 1. The mean 
recovery was found to be 96.09 - 98.43 % with 
relative standard deviation less than 5 %. 
Intraday and inter day accuracy was found to be 
96.09 - 98.43 % and 90.86 - 97.93 % 
respectively, with relative standard deviation less 
than 5 %. This indicated that the method was 
reliable, accurate and precise. Moreover, the 
method was found to be robust because it was 
not affected by a small change in mobile phase 




Figure 2: HPLC chromatogram of blank plasma  
 
 
Figure 3: HPLC chromatogram of caffeic acid-spiked plasma 
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Table 1: Recovery, intra-day and inter-day accuracy and precision of caffeic acid from spiked plasma by HPLC 
 
Concentration 
(µg/mL) Recovery (n = 3) 
Mean          SD                                                        
(%)               (%) 
Intra-day (n = 6) 
     
Precision                  
%                RSD  
Inter-day (n=6) 
Accuracy   Precision     
(%)           RSD 
2.5 96.09 2.39 96.09 2.14 90.86 2.15 
50.0 96.19 4.77 96.19 4.26 95.58 4.26 
100.0 98.43 3.02 98.43 2.70 97.93 2.69 
 
Figure 4: Plasma concentration of caffeic acid versus time plot; each point represents the mean of six rats 
 
Table 2: Pharmacokinetic parameters of Syzygium cumini seed extract (based on caffeic acid, n = 6) 
 
Pharmacokinetic parameter Mean SD 
Area under curve 0-12h (AUC0-last , µg.h/mL) 17.88 1.98 
Area under curve 0-∞ (AUC0-∞ ,µg.h/mL) 22.87 2.12 
Area under mean curve (AUMC) 73.16 11.95 
Mean resident time (MRT, h) 4.092 0.18 
Half-life, (T1/2 , h) 0.14 0.01 
Concentration maximum (Cmax, µg/mL) 5.96 0.49 
Time to achieve maximum concentration (Tmax, h) 1.00 0.00 
Elimination constant (Kel, h-1) 4.99 0.178 
Clearance (Cl) 21.86 1.43 
Volume of distribution (VD) 4.378 0.16 
 
Pharmacokinetic profile of caffeic acid 
 
The plasma samples of each rat, taken at 
different time intervals were analyzed to 
determine the contents of caffeic acid, which 
were then used to calculate various 
pharmacokinetics parameters. The plasma 
concentration versus time curve (Figure 4) 
indicated that caffeic acid of the extract followed 
a fast and steady absorption, which reached the 
maximum at 1.00 h. The steady fall in the 
concentration from 1 – 2 h showed disposition of 
caffeic acid from the plasma to more perfused 
tissues. After 2 h, elimination of the drug was 
found to be slow which indicated the excretion 
from plasma and dynamic equilibrium by moving 
the drug from tissue to blood. 
 
The pharmacokinetics of caffeic acid is given in 
Table 2. These results showed that the 
absorption of caffeic acid from the oral route was 
quite fast, followed by a biphasic elimination. 
Mean resident time and volume of distribution (4 
h) indicated that the body was exposed to the 
drug for a lesser time. The fast decline in 
concentration may be due to disposition or 
metabolism. In the present study, an oral dose of 
the extract (500 mg/rat), equivalent to 37.135 
mg, was administered and a much lesser amount 
was absorbed (Cmax= 15.2 µg/mL). Our results 
were found to be consistent to that reported 
earlier. The report indicated that 20 % of the 
dose of caffeic acid was absorbed into 
enterocytes from the intestine, from where only 
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19.5 % (0.5 % secreted into the intestine) passed 
into mesenteric vein leading to the liver wherein 
the concentration was further decreased due to 
biliary secretion (0.4 %) resulting 19.1 % 




The separation of caffeic acid from rat plasma 
was achieved using solvent extraction. For such 
purpose, a combined approach- deproteination 
and liquid-liquid extraction- was employed. 
Deproteination was achieved using acetonitrile 
and extraction was carried out using methanol. 
The varying amounts of acetonitrile were used to 
achieve de-proteination.  Acetonitrile (200 µL) 
was found to be enough to de-protein 500 µL of 
the rat plasma. Likewise, 800 µL of methanol 
gave more than 95 % recovery, which indicated 
that the method is good to be used to study 
pharmacokinetics of extracts of seeds of the 
plant. Moreover, the method was found to be 
accurate, precise and robust.  
 
The drug must reach quickly at the site of action 
in a suitable concentration. At the same time 
drug must be eliminated from the body in lesser 
time to avoid the drug exposure. In the present 
study, caffeic acid absorption from the 
gastrointestinal tract was fast, but in lower 
amount than the dose administered (19.1 %). 
The clearance (21.86 h) and volume of 
distribution (4.378) indicated that the drug will be 
safer as the exposure was for a lesser time. 
 
Caffeic acid is a well-known phenolic compound, 
which is widely distributed in fruits and 
vegetables [23]. The compound is reported to 
have significant antioxidant activity [24-26]. 
However, results of the present study indicate 
that oral bioavailability of this compound needs to 




The results obtained indicate the low but fast oral 
bioavailability of caffeic acid from the methanol 
seed extract of Syzygium cumini. Peak plasma 
concentration is achieved in 1 h which suggests 
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